Hints and tips:
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...The AU will pay $6.75 a dose for the BioNTech/Pfizer vaccine and $10 for Johnson & Johnson’s, a single-dose product....
...Pfizer similarly has all of its non-US production situated inside the bloc....
...Martin Marshall, chair of the royal college of GPs, said there was still considerable uncertainty around which vaccines doctors would be allowed to administer, and when....
...After such strong reads from the first two releases (three if we count Russia’s Sputnik V), the disappointing AZN figures were perhaps bound to prompt downward pressure on the company’s shares....
...In August, Russia became the first country to approve a Covid-19 vaccine — named Sputnik V — for civilian use, but western experts cast doubt on its efficacy and safety....
...Martin Marshall, head of the Royal College of General Practitioners, said: “Right now, the capacity of the service to deliver [vaccinations] is pretty well aligned to the availability of the vaccine . ....
...AstraZeneca Plc has made a preliminary approach to rival drugmaker Gilead Sciences Inc. about a potential merger, according to people familiar with the matter, in what would be the biggest health-care deal...
...Philip Marshall, the QC representing Lehman Brothers Ltd, is expected to argue that it was a mistake that led to it owning a single share in LBIE and, as a result, it would be disproportionate to allow the...
...If you’re not the romantic type, take a seat outside on the brutalist concrete street furniture designed by studios Maynard and Marshalls....
...Merger and acquisition activity has also buoyed valuations, with $10bn-plus deals announced between Allergan and Actavis, Covidien and Medtronic, Hospira and Pfizer as well as CareFusion and Becton Dickinson...
...Executive chairman Steve Marshall is right to consider breaking up this serial underachiever....
...The possibility of a Pfizer/AstraZeneca deal still has the politicians talking (the chief executives of both were hauled before the UK parliament this week)....
...The so-called “Marshall Plan” – which has provided investments of more than €4.5bn since its introduction in 2006 by the socialist-led regional government – as well as a new era of more market-oriented local...
...beyondbrics India v China: a new race in biopharmaceuticals, beyondbrics...
...dividend - Lansley draws fire after delaying A&E decision - Tchenguiz brothers angry over arrests - Tullett in interdealer broker tie-up talks with CFT - Flower pots add steel to Marshalls...
...In regionals, Marshall & Islely lost 3.4 per cent to $5.73 and Regions Financial sunk 5.2 per cent to $6.21....
...Pfizer, the largest US drugmaker by market value, inched down 0.7 per cent to $14.54 as the stock being removed from the “conviction buy” list at Goldman Sachs....
...ESPN executives on stage to talk about their forthcoming nature and sports 3D channels (25 FIFA World Cup matches will be televised in 3D by ESPN this summer). “[3D] is the perfect example of how we will marshall...
...Last week’s US jobs report has knocked investor confidence, and those predicting a V-shaped recovery are finding it harder to justify their positions....
...This spurred groups such as Pfizer of the US and Roche of Switzerland to strike multi-billion-dollar deals during the first half of this year....
...“The next significant catalyst for the airline sector will be upgrades on lower fuel costs,” said analyst Tim Marshall....
...Kindler, Chairman and CEO, Pfizer Inc., USA Klaus Kleinfeld, President and CEO, Siemens AG, Germany Mustafa V....
...–Marshall N. Carter, Chairman, NYSE Group, Inc....
..."In many ways, I see myself as a direct beneficiary of what Thurgood Marshall did," Mr Frazier says. "I didn't have to decide that Marshall was a hero of mine....
International Edition